the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

South Korea’s Hanwha Qcells to invests US$2.5b in US solar panels

NEW YORK: A South Korea company said on Wednesday (Jan 11) that it plans to invest US$2.5 billion (RM10.9 billion) in US solar panel manufacturing in order to take advantage of tax breaks included in President Joe Biden’s climate plan.

Biden said the plan by Hanwha Qcells would be “the largest solar investment in US history” and create thousands of jobs in the southern state of Georgia.

The project would benefit from Biden’s massive Inflation Reduction Act, a US$369 billion spending plan that includes massive tax breaks for clean energy, including solar power.

The spending bonanza has caused alarm among US trade partners in Europe and Asia who fear the plan will starve their own industries of much needed investment.

The European Union also sharply criticizes provisions in the IRA that would limit US tax breaks on buying electric vehicles to cars made in the US, Canada and Mexico.

Hanwha Qcells said it plans to expand the firm’s manufacturing capacity at its plant in the city of Dalton, Georgia, and to build a new plant in Cartersville.

Building solar panels in the United States will also provide help towards the Biden administration’s goal of dropping China as a manufacturer for crucial imports. – AFP

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings